Mind Body Intervention for Long COVID-19

Description

The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control

Conditions

Long COVID, Post-Acute Sequelae of COVID-19, COVID Long-Haul

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control

Mind Body Intervention for Long COVID

Mind Body Intervention for Long COVID-19

Condition
Long COVID
Intervention / Treatment

-

Contacts and Locations

Boston

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adult (≥ 18 years of age)
  • 2. Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
  • 3. Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
  • 4. A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
  • 5. Symptoms present at least 3 day a week for a minimum of 3 months
  • 6. Willingness to engage in a Mind-Body intervention
  • 1. Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
  • 2. Hospitalization in an intensive care unit for acute COVID-19 infections
  • 3. Age greater than 65 years
  • 4. Diagnosis of dementia or similar cognitive impairment
  • 5. Active addiction disorder (e.g. cocaine) that would interfere with study participation
  • 6. Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Beth Israel Deaconess Medical Center,

Michael Donnino, MD, PRINCIPAL_INVESTIGATOR, Beth Israel Deaconess Medical Center

Study Record Dates

2026-01